Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, ...

The Rs 3,395 crore Initial Public Offering (IPO) of Anthem Biosciences, the Bangalore-based contract research, development, ...

Anthem ticks all the boxes. But with lofty valuations and limited margin headroom, analysts warn the IPO may not deliver ...

Anthem Biosciences' IPO fully subscribed, investors optimistic about growth prospects amid global pharma shift from China to ...

Among investor categories, Non-Institutional Investors (NIIs) have shown the highest interest, bidding 1.55 times their ...

Anthem Biosciences IPO sees 20% GMP premium and strong subscriptions on Day 2; check allotment, listing, and key dates now!

The mainline issue will close for public subscription on Wednesday, July 16. The basis of allotment of shares is likely to be ...

The initial public offering (IPO) of Anthem Biosciences was fully subscribed by the second day of bidding on Tuesday.The IPO ...

Anthem Biosciences, ₹3,395 crore IPO was fully subscribed by Day 2, with strong interest from non-institutional investors, ...

Anthem Biosciences has launched its IPO on July 14, closing on July 16. The ₹3,395 crore offer is entirely for sale by ...

Anthem Biosciences raised ₹1,016.02 crore from 60 institutional investors ahead of its IPO launch on July 14. The offering, ...